Tenax Therap (TENX)
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-10...
- Open
- 2.105
- High
- 2.110
- Low
- 1.730
- Prev. Close
- 2.130
- Volume
- 17.24M
- Turnover
- 32.07M
- Avg Price
- 1.861
- Bid/Ask Ratio
- 97.78%
- Amplitude
- 17.84%
- 52wk High
- 19.400
- Volume Ratio
- 11.88
- Turnover Ratio
- 382.54%
Tenax Therap Analyst Rating
View moreForecast & Rating
Aug 31, 2026Price forecast
$11.70535.87%
Forecast & RatingBuy
10analysts
- Strong buy60.00%
- Buy10.00%
- Hold30.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 47 minutes ago
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month
- benzinga_article · 18 hours ago
This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
- PUBT · 2 days ago, 07:21 AM
Tenax presents Phase 3 LEVEL data showing TNX-103 boosts 6-minute walk distance in lower baseline subgroup
- StockTitan · Aug 28 at 11:21 PM
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 | TENX Stock News
- businessinsider · Aug 25 at 06:45 AM
Tenax rises on over $1.8M insider buying
- Global Report · Aug 25 at 06:32 AM
Fintech Revamps and Biotech Misses Drive the Latest Tech Fringe Volatility
